2026-10-25
Expro clears the business-activity screen and the figures we can measure look clean, but one or more financial figures are still pending, so the verdict is not final yet.
NAS100 27,087 +1.72%
S&P 7,401 +0.65%
GOLD $4,073 −1.00%
BTC $75,828 −0.15%
VIX 24.55 −12.88%
latest tape · as of 20:03 UTC
The Screen · Energy · Oil & Gas Equipment & Services
Expro Group Holdings N.V.
XPRO · the NYSE · USD · Market cap $1.6B · 7,000 employees
Expro Group Holdings N.V.
Not yet scored12.84 USD
Price as of 5 Nov 2026Daily close, not a live quote
Screened 2026-11-05 · the tape above runs as of 20:03 UTC · two dates, stated on purpose · verdict and workings shown in full · never trimmed
Key facts today
- Price12.84 USD at the 5 Nov 2026 close
- Our value readFair vs our fair value, as of 5 Nov 2026
- Our regime readDistribution, as of 5 Nov 2026
- Ethical screenNot yet scored
- Last reviewed5 Nov 2026 (1 days ago)
- Release timesRelease and earnings times on your chart: Event Guard Mentor
A summary of the dated readings below, not a live quote and not advice.
PRICE · ONE YEAR
Our fair-value range: $13.44 to $15.46, base estimate $13.44 (screen dated 2026-11-05).
- Trend Distribution
- Insiders no filings inside 60 days, left as found
- Positioning no disclosures inside 60 days, left as found
- Options no verdict drawn today, left as found
- Ethical screen not yet scored
Price12.84 USD
Fair value13.44
Ethical score70.0/100
Value readFairas of 5 Nov 2026
Our investment reviews on this name
2026-11-01Read Accumulation17.26-25.6% to today Markdown gives way to Accumulation
2026-10-27Read Markdown16.77-23.4% to today ✓Accumulation gives way to Markdown first Markdown read since October
2026-10-22Read Accumulation16.77-23.4% to today Markdown gives way to Accumulation
2026-09-17Read Markdown16.44-21.9% to today ✓Accumulation gives way to Markdown after an 11% slide in 4 weeks
Our analytic regime reads on this name, dated and marked against the screened price. Small sample per name, and separate from the daily-framework accuracy on the Track Record page.
The full research record, in depth, below
This name holds its distribution label.
Expro Group Holdings N.V. holds its Distribution at $12.84. Consolidating, no directional conviction, held for 76 days.
| Phase | Distribution · caution |
| Quantitative state | Consolidating, no directional conviction, held for 76 days |
| Price at the screen | $12.84 |
| Valuation | 1,386.00 trailing · 12.47 forward price to earnings |
| Values screen | Not scored · score 70.0 |
Five Screens, Shown in Full
This security has not been fully scored against the values screen yet.
| Test | Figure | Limit | What it means | Status |
|---|---|---|---|---|
| Business activity | Permissible | Core business clean | Its core business isn't built on prohibited lines: no gambling, alcohol, tobacco, weapons, or interest-based lending. | Pass |
| Debt load | 7.46% | Below 33% | Interest-bearing debt is just 7.5% of its assets, well under the one-third ceiling: it does not run on borrowed money. | Pass |
| Interest-bearing cash | 0.00% | Below 33% | Cash held in interest-bearing accounts and securities is 0.0% of assets, under the one-third limit. | Pass |
| Receivables | 29.79% | Below 49% | Money owed to the company is 29.8% of assets, under the 49% limit. | Pass |
Five checks adapted from AAOIFI screening standards: business activity plus four balance-sheet ratios. All five must pass for ethical clearance. Every figure is arithmetic on public accounts, not judgement.
The Ethical ReadThe Read, in Plain English
Expro clears the business-activity screen and the figures we can measure look clean, but one or more financial figures are still pending, so the verdict is not final yet.
Read as at 2026-11-05. It updates when the underlying figures move, and past reads are kept below.
2026-09-24
Clears
Expro clears all five screens. Its business is in a permissible area, its interest-bearing debt is about 7%, inside the ~33% line, and almost none of its income is interest, so it passes.
Earlier reads, kept as written. The ethical profile is tracked over time, not overwritten.
What the Numbers Say It Is WorthThe Fair Value Range
Our analysis reads Fair vs our fair value, as of 5 Nov 2026: it trades above our $13.44 fair value estimate, 6.90% revenue growth.
How a fair value is estimated: discounted cash flow (DCF).
Fair value range in USD, drawn from the 2026-11-05 screen. The gold marker is the market price at the same screen. A 4.5% discount to the base estimate.
Third-party analyst targets. The average target sits +36% from the screen price.
Reading the gap · Our more conservative model reads it as roughly fairly valued here, while the Street is more bullish: a quality-at-a-fair-price name rather than a deep-value one.
Price History & ProjectionsWhere our models see it going: fair-value estimate $13.44, with a range of $13.44 to $15.46, dated to the 2026-11-05 screen.
Fair value and rating are our own model estimates; the Street's range reflects third-party analyst estimates. Analysis, not advice.
The Business, in Plain WordsOil services firm trading above its worth
Picture a rig crew waiting for the next price spike to keep the cash flowing. Expro sits in that exact spot, offering well construction and testing services across regions where activity tracks crude prices rather than steady demand. The business shows negative revenue growth, wafer-thin margins and returns on equity that barely register, while the shares sit above our fair value with no opportunity rating attached.
The forward multiple looks modest at first glance, yet the company is cycling through lower activity and the market is already pricing in a recovery that may not arrive on schedule. Analysts lean buy with a target near the current price, but that view overlooks how thin the returns remain even at current levels. The ethical screen clears without issue.
Cyclical businesses often flash low multiples right when earnings peak, and this one carries the classic warning signs of thin profitability and revenue already sliding. Any rebound would need sustained higher oil prices and fresh contracts that have yet to materialise in volume. Analysis, not advice.
| Forward P/E | 12.5xpriced for continued growth |
| Trailing P/E | 1,386.0xexpensive: the price assumes strong growth ahead |
| EPS, trailing | 0.01 |
| EPS, forward | 1.11 |
| Revenue growth | +6.9%slow but positive growth |
| Profit margin | 0.1%barely profitable |
| Return on equity | 0.1%a modest return on shareholder capital |
| FCF yield | 11.07% |
| Debt to equity | 0.23minimal debt: a conservative balance sheet |
| Current ratio | 1.82healthy short-term liquidity |
| Short interest, float | 0.08% |
| 52-week range | 12.44 - 19.23 |
| Market cap | $1.6B |
| Employees | 7,000 |
Another profit measure, before interest, tax and non-cash costs: EBITDA.
The risks · The things to watch: it's a small-cap, so the share price can swing harder than the market.
Plain-English interpretation of our own screen data. Analysis, not advice.
Where & How to TradeXPRO trades on the NYSE. As a listed security it is accessible through almost any international broker offering its home market. New to this, or investing from abroad? Our guide to accessing global markets covers brokers, currencies and the practical steps.
Every Entry, As Written
2026-11-03
Accumulation $17.26
+0.0% Entry 23
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: not fully scored yet. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B. Technically it is holding around 3% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 73%. Our forward projection puts the odds of a 10% gain over the next month near 24%. The street (5 analysts) rates it hold, with a mean price target of $18. It reported earnings in this window, a natural checkpoint for the thesis.
2026-11-02
Accumulation $17.26
+0.0% Entry 22
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: not fully scored yet. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B. Technically it is holding around 3% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 73%. Our forward projection puts the odds of a 10% gain over the next month near 24%. The street (5 analysts) rates it hold, with a mean price target of $18. It reported earnings in this window, a natural checkpoint for the thesis.
2026-11-01
Accumulation · changed $17.26
+1.9% Entry 21
The framework has shifted from markdown to accumulation since the last review. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved up 1.9% since our last review. Ethical screening: not fully scored yet. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B. Technically it is holding around 3% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 73%. Our forward projection puts the odds of a 10% gain over the next month near 24%. The street (5 analysts) rates it hold, with a mean price target of $18. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-31
Markdown $16.93
+0.0% Entry 20
The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: not fully scored yet. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B. Technically it is holding around 3% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 73%. Our forward projection puts the odds of a 10% gain over the next month near 24%. The street (5 analysts) rates it hold, with a mean price target of $18. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-30
Markdown $16.93
+0.0% Entry 19
The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: not fully scored yet. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B. Technically it is holding around 3% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 73%. Our forward projection puts the odds of a 10% gain over the next month near 24%. The street (5 analysts) rates it hold, with a mean price target of $18. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-29
Markdown $16.93
+1.0% Entry 18
The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved up 1.0% since our last review. Ethical screening: not fully scored yet. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B. Technically it is holding around 3% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 73%. Our forward projection puts the odds of a 10% gain over the next month near 24%. The street (5 analysts) rates it hold, with a mean price target of $18. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-28
Markdown $16.77
+0.0% Entry 17
The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: not fully scored yet. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B. Technically it is holding around 3% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 73%. Our forward projection puts the odds of a 10% gain over the next month near 24%. The street (5 analysts) rates it hold, with a mean price target of $18. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-27
Markdown · changed $16.77
+0.0% Entry 16
The framework has shifted from accumulation to markdown since the last review. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: not fully scored yet. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B. Technically it is holding around 3% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 73%. Our forward projection puts the odds of a 10% gain over the next month near 24%. The street (5 analysts) rates it hold, with a mean price target of $18. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-22
Accumulation · changed $16.77
+6.9% Entry 15
The framework has shifted from markdown to accumulation since the last review. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved up 6.9% since our last review. Ethical screening: not fully scored yet. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C. Technically it is holding around 1% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 73%. Our forward projection puts the odds of a 10% gain over the next month near 24%. The street (5 analysts) rates it hold, with a mean price target of $18. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-21
Markdown $15.69
+0.0% Entry 14
The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C. Technically it is holding around 1% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 73%. Our forward projection puts the odds of a 10% gain over the next month near 24%. The street (5 analysts) rates it hold, with a mean price target of $18. It reported earnings in this window, a natural checkpoint for the thesis.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.
- 3 small-cap stocks we find risky Yahoo Finance · 14d ago
- Expro Ltd Schedules Third Quarter 2026 Earnings Release and Conference Call Yahoo Finance · 15d ago
- 1 Cash-Heavy Stock to Keep an Eye On and 2 We Question Yahoo Finance · 24d ago
- Oilfield Services Stocks Q2 Recap: Benchmarking Expro (NYSE:XPRO) Yahoo Finance · 28d ago
- Expro and Noble Corporation Shares Are Soaring, What You Need To Know Yahoo Finance · 29d ago
Headlines from third-party outlets, linked for reference: not our reporting, not advice.
INVXInnovex International, Inc.
FLOCFlowco Holdings Inc.
NESRNational Energy Services Reunited Corp.
NEXTNextDecade Corporation
HLXHelix Energy Solutions Group, Inc.
EROKEagleRock Land, LLC
Screened names in the same industry · explore each on its own page.
| Period | Price then | Price return | Divs per share | $1,000 became | Total return |
|---|---|---|---|---|---|
| 1 month | $15.86 | +3.5% | · | $1,035 | +3.5% |
| 2 months | $16.69 | -1.7% | · | $983 | -1.7% |
| 3 months | $15.96 | +2.8% | · | $1,028 | +2.8% |
| 6 months | $14.64 | +12.1% | · | $1,121 | +12.1% |
| 1 year | $9.47 | +73.3% | · | $1,733 | +73.3% |
| 2 years | $21.38 | -23.3% | · | $768 | -23.3% |
| 3 years | $18.45 | -11.1% | · | $889 | -11.1% |
| 5 years | $20.34 | -19.3% | · | $807 | -19.3% |
Historical returns from market close data. Past performance does not guarantee future results.
This entry now belongs to the ledger. Whatever XPRO does next, these words stay.
Membership
Thirteen thousand names carry this page. One desk keeps them honest.
Membership opens the full screen archive, the composites built from it, and the daily coverage that prices what the screen approves.
Join the deskScreening is research, not a fatwa and not financial advice. Figures are drawn from public accounts at the screen date shown. Always manage your risk.